Determination of breast cancer prognosis after neoadjuvant chemotherapy: comparison of Residual Cancer Burden (RCB) and Neo-Bioscore

BACKGROUND: To compare RCB (Residual Cancer Burden) and Neo-Bioscore in terms of prognostic performance and see if adding pathological variables improve these scores. METHODS: We analysed 750 female patients with invasive breast cancer (BC) treated with neoadjuvant chemotherapy (NAC) at Institut Cur...

Descripción completa

Detalles Bibliográficos
Autores principales: Laas, Enora, Labrosse, Julie, Hamy, Anne-Sophie, Benchimol, Gabriel, de Croze, Diane, Feron, Jean-Guillaume, Coussy, Florence, Balezeau, Thomas, Guerin, Julien, Lae, Marick, Pierga, Jean-Yves, Reyal, Fabien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039034/
https://www.ncbi.nlm.nih.gov/pubmed/33558711
http://dx.doi.org/10.1038/s41416-020-01251-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039034/
https://www.ncbi.nlm.nih.gov/pubmed/33558711
http://dx.doi.org/10.1038/s41416-020-01251-3

Ejemplares similares